NCT01799538 2026-03-11
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
Clinical Trials
41 trialsNCT00001465 2026-02-20
Study of the Disease Process of Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03304678 2026-02-18
Discovery of Sirolimus Sensitive Biomarkers in Blood
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT06160310 2026-01-23
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Children's Hospital Medical Center, Cincinnati
Recruiting
NCT05467397 2026-01-21
Feasibility of [11C]Acetate-PET in LAM and TSC
Brigham and Women's Hospital
Phase 1/2 Active not recruiting
NCT06889168 2026-01-21
LAMP-2
Columbia University
Phase 1 Recruiting
NCT07304856 2025-12-26
Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
University of Milan
Recruiting
NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05676099 2025-07-08
TSC Biosample Repository and Natural History Database
National Tuberous Sclerosis Association
Recruiting
NCT02432560 2024-12-24
MIDAS
University of Cincinnati
Recruiting
NCT03150914 2024-12-24
MILED
University of Cincinnati
Phase 3 Active not recruiting
NCT05727852 2024-07-30
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
I.M. Sechenov First Moscow State Medical University
Enrolling by invitation
NCT06405997 2024-05-09
The Genotype and Phenotype of Lymphangioleiomyomatosis
National Taiwan University Hospital
Recruiting
NCT01353209 2024-04-17
TRAIL
University of Cincinnati
Phase 2 Completed
NCT00414648 2023-11-02
MILES
University of Cincinnati
Phase 3 Completed
NCT05323370 2023-03-29
LAM-CAK
University Hospital, Tours
Completed
NCT02654340 2023-02-10
TuScCom
CENTOGENE GmbH Rostock
Terminated
NCT03253913 2023-02-01
RESULT
University of Cincinnati
Phase 2 Completed
NCT05617105 2022-11-15
PEComesCells
University Hospital, Strasbourg, France
Unknown
NCT02325505 2022-08-04
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
InCor Heart Institute
Completed
NCT05190627 2022-01-27
LORALAM
Institut d'Investigació Biomèdica de Bellvitge
Phase 2 Unknown
NCT02484664 2022-01-20
COLA
Brigham and Women's Hospital
Phase 2 Completed
NCT03193892 2021-09-24
A National Registry on Chinese Patients With Lymphangioleiomyomatosis
Peking Union Medical College Hospital
Recruiting
NCT03525834 2021-09-09
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Novartis
Phase 4 Completed
NCT00366509 2021-08-02
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
National Institutes of Health Clinical Center (CC)
Completed
NCT04577937 2021-03-18
Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Unknown
NCT01059318 2020-11-19
A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Novartis
Phase 2 Completed
NCT02061397 2020-08-25
SOS
University of Pennsylvania
Phase 1/2 Completed
NCT03131999 2020-06-16
LAMP-1
Medical University of South Carolina
Phase 1/2 Completed
NCT04184193 2020-01-21
Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)
Schön Klinik Berchtesgadener Land
Completed
NCT00552955 2019-03-06
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
National Institutes of Health Clinical Center (CC)
Completed
NCT02859194 2018-07-18
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients
Yonsei University
Phase NA Completed
NCT02116712 2016-11-30
The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Baylor College of Medicine
Phase 1 Completed
NCT00005486 2016-02-18
Lymphangioleiomyomatosis (LAM) Registry
National Heart, Lung, and Blood Institute (NHLBI)
Completed
NCT02009241 2015-12-11
Pulmonary Rehabilitation in Lymphangioleiomyomatosis
University of Sao Paulo General Hospital
Phase NA Completed
NCT00989742 2015-12-02
Doxycycline In Lymphangioleiomyomatosis (LAM)
University of Nottingham
Phase 4 Completed
NCT00960895 2011-10-27
LAM-PH
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Completed
NCT00005906 2010-04-30
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00490789 2008-04-30
TESSTAL
Cardiff University
Phase 2 Unknown
NCT00001869 2008-03-04
Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
National Institutes of Health Clinical Center (CC)
Completed
NCT00457808 2007-04-09
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati
Phase 2 Completed